Some previous groups have indicated that the cancer risk, perhaps caused by a higher tendency of relapses and thus higher cumulative immunosuppressive drug doses, is higher in C-ANCA/PR3-ANCA than in P-ANCA/MPO-ANCA positive patients [5, 13]. The gene discussed is PRTN3; the disease is cancer.